180 Life Sciences (ATNF)
(Delayed Data from NSDQ)
$3.54 USD
+0.26 (7.93%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $3.37 -0.17 (-4.80%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Dividend Yield (TTM)
180 Life Sciences Corp.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ATNF 3.54 +0.26(7.93%)
Will ATNF be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ATNF based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for ATNF
EXCLUSIVE: July's 20 Most-Searched Tickers On Benzinga Pro — Where Do Opendoor, Nvidia, Apple Stock Rank?
180 Life Sciences (ATNF) Announces $425M PIPE Deal for Ethereum Focus
Another Ethereum Treasury Play: 180 Life Sciences Raises $425 Million To Buy ETH
180 Life Sciences to raise $425M, rebrand as ETHZilla to launch Ethereum treasury strategy
180 Life Sciences (ATNF) to Transition into ETHZilla with New Treasury Strategy